Tablets & Capsules

2017 Annual Buyers Guide

Issue link: http://www.e-digitaleditions.com/i/751389

Contents of this Issue

Navigation

Page 13 of 157

8 November 2016 Tablets & Capsules The role of NIR spectroscopy in meeting the PAT chal- lenge. Frederick H. Long. March 2007, p. 20. A simple test to differentiate gelatin from hypromellose cap- sules. Enrique Requejo Gabás, Fernando Díez Menendez, Luis Polo Díez, and Nour Kayali. July 2013, p. 16. Simulated tabletting, real-world pay-off. Kendal Pitt. Back Page, September 2010, p. 56. Tablet exam: Using dynamic compaction analysis to ensure successful formulations. Joe Domingue and Michael Gamlen. May 2016, p. 28. Tabletability, compactibility, and compressibility: What's the difference? Robert Sedlock. September 2016, p. 19. Testing powder flowability. Robert G. McGregor. March 2011, p. 20. Tooling supplier, university seek cure for sticking. July 2013, p. 40. Tracking bulk density to maximize tablet production. Vinnie Hebert. March 2016, p. 27. Understanding maximum compression force. Kevin Queensen. September 2015, p. 10. Update on the FDA's spectral library of excipients. Philip H. Merrell, Lucinda Buhse, and Jason D. Rodriguez. July 2013, p. 27. Using an automated workstation to improve operations and simplify investigations. C.J. Moynihan and Robert C. Houser. May 2012, p. 23. Using low-field MRI to improve tablet dissolution testing. James Butler and Kevin Nott. January 2010, p. 25. Using static image analysis to size crystalline particles. Patrick O'Hagan, Kerry Hasapidis, Vincent Chapeau, and Christian Godino. May 2008, p. 30. Using terahertz spectroscopy to map tablet cores and coat- ings. Mark Sullivan, Edward King, Eiji Kato, David Heaps, Richard McKay, and Xiao Hua Zhou. October 2013, p. 10 What standard? Investigation raises questions about DNA testing. Evan Hansen. April 2015, p. 32B. You can't correct for randomness. Ben Locwin. Back Page, October 2013, p. 48. Anti-counterfeit techniques Detecting counterfeit drug products via impurity mapping. Aurélie Bart, Ziyang Su, Karl V. Wood, Stephen R. Byrn, and M. Teresa Carvajal. October 2009, p. 24. FDA hones guidance on PCIDs. Peter M. O. Wong. Back Page, April 2012, p. 56. Fighting counterfeits requires on-dose protection. Dean Hart. July 2009, p. 34. On-dose authentication: Walking softly, prepared to stick. Peter M.O. Wong. March 2011, p. 28. Track and trace: Options for compliance. Mark Feher. May 2013, p. 12. Auditing Excipients in the news. Matthew Knopp. Back Page, July 2013, p. 48. Five questions to ask your suppliers to ensure quality and control cost. John Davidson and David Simpson. October 2012, p. 32B. GMP compliance: The top seven pitfalls. Greta Houlahan. January 2012, p. 32B. Gaining reassurance from third-party auditing. Edward Wyszumiala and Manny Jimenez. January 2010, p. 32B. Have a plan before the FDA arrives. Bryan J. Coleman. Back Page, October 2016, p. 52. On-site audits of excipient suppliers. Irwin B. Silverstein and Jim Morris. Eye on Excipients, September 2014, p. 41. Safety evaluations of new excipients. Christopher DeMerlis, Elaine V. Knight, R. Christian Moreton, and Robert E. Osterberg. Eye on Excipients, April 2011, p. 39. Stability testing. Philip H. Merrell. Eye on Excipients, October 2012, p. 33. The 10 most common 483s and how to avoid them. Carol Tousey. October 2010, p. 24. Third-party auditing. Philip H. Merrell. Eye on Excipients, March 2010, p. 37. Bioavailability Improving the bioavailability APIs for delivery in oral solid dosage forms. Robert J. Timko. July 2016, p. 29. Functional lipids and self-emulsifying drug delivery sys- tems (SEDDS) to overcome the poor solubility and per- meability of today's APIs. John K. Tillotson. Eye on Excipients, May 2016, p. 41. Blending Advantages of using IBCs for blending and roll compaction. Vic Shulman. January 2006, p. 36. Effect of sampling methods on vitamin D blending unifor- mity. Wenming Zeng, Dan Wang, and Doug Roper. October 2016, p. 17. FDASIA's effect on excipients. Bretta Lichtenhan, Dale Carter, Megan Bevill, Katherine Ulman, and Julie Budnick. Eye on Excipients, October 2013, p. 39. Powder blenders and NIR: A brief overview. Matthew N. Bahr. May 2008, p. 38. Powder blending and ingredient agglomeration Fernando Muzzio. Back Page, October 2014, p. 48. Pro-X Nutraceuticals triples mixing capacity while reducing labor, waste. September 2008, p. 32H. Rotary batch mixer boosts throughput at Arizona Nutritional. July 2013, p. 36. Seeking stronger bi-layer tablets. Changquan Calvin Sun. Back Page, July 2014, p. 48. Selecting solids mixers: Factors to consider. Peter van der Wel. July 2008, p. 32. Smoothing out lubrication during blending. John A. McCarty. Back Page, July 2008, p. 56.

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - 2017 Annual Buyers Guide